Medication info
Crechek Tablet 2.5 mg (Rosuvastatin Calcium)

Crechek Tablet 2.5 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›2.6mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202402817 · Approved 2024.11.27 · Insurance code 645307120

Summary

Main use
Improvement of primary hypercholesterolemia and mixed hyperlipidemia
Who uses it
Adults
Adult dosage
Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response; the dose may be increased to a maximum of 20 milligrams per day. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
View approved original text

This medication is used as an adjunct for patients with primary hypercholesterolemia and heterozygous familial hypercholesterolemia (type IIa), as well as combined hyperlipidemia (type IIb) when not adequately controlled by diet and exercise. It assists in lowering blood cholesterol and triglyceride levels, helping prevent cardiovascular diseases. When taken alongside a consistent diet, it is effective in improving blood lipids. Therefore, this medication plays a crucial role in the treatment of hyperlipidemia.

Dosage and Administration

Adult dosage

Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response; the dose may be increased to a maximum of 20 milligrams per day. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Precautions

This medication should not be used by individuals allergic to certain components. Patients with liver function impairment or significantly elevated liver enzymes should not take this medication. Patients with muscle diseases or any symptoms of muscle abnormalities should not be administered this medication. The risk of side effects from this medication increases when taken in conjunction with the immunosuppressant cyclosporine, hence concurrent use should be avoided. Patients with severely impaired kidney function, pregnant or breastfeeding women, should not use this medication, and women of childbearing age should employ appropriate contraceptive methods to reduce the chance of pregnancy. High-dose administration is prohibited for patients at high risk of muscle damage. Patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. Patients who consume alcohol excessively or have a history of liver disease should undergo liver function testing before use and should take it with caution. Muscle pain, weakness, and myopathy can occur, so if these symptoms arise, immediate consultation with a physician is necessary. If severe muscle abnormalities are present, the use of this medication should be discontinued following the doctor's instructions. This medication may temporarily raise liver enzyme levels in some patients, so regular liver function tests are required. Interactions may occur when taken with other medications, so it is essential to inform your physician or pharmacist of any currently taken medications. Pregnant or breastfeeding women should not use this medication, nor should women planning to become pregnant due to necessary precautions. In case of overdose, there is no specific antidote, and symptoms should be monitored while receiving appropriate treatment. Caution is advised during activities like driving or operating machinery as dizziness may occur.

Side effects

dyspepsia, pruritus, immune thrombocytopenic purpura, facial edema, herpes zoster, vulvar pruritus, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, headache, dizziness, ALT elevation, chest pain, cough, myalgia, CK elevation, constipation, AST elevation, asthenia, arthralgia, fatigue, numbness, paresthesia, chest discomfort, nausea, abdominal pain, diarrhea, anorexia, abdominal distension, itching, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.